跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 109,758 条关于
“Sichuan Cancer Hospital & Institute”
全部
109,758
临床试验
82,380
药物
3,751
机构
4,111
资讯
19,516
去年
Immunotherapy Plus Chemoradiation Improves Outcomes in Esophageal Cancer
去年
Sichuan Biokin's First-in-Class EGFR/HER3 ADC Advances to Phase 3 Trials Across Multiple Cancer Types
去年
Kelun-Biotech's SKB571 Receives Green Light for Clinical Trials
去年
Kelun-Biotech's SKB445 ADC Receives NMPA Approval for Advanced Solid Tumor Trials
2年前
Real-World Data Confirms Predictors of Exceptional Response to HER2-Targeted Therapy in Metastatic Breast Cancer
去年
Sacituzumab Tirumotecan (Sac-TMT) Approved in China for Advanced TNBC
去年
Kelun-Biotech's SKB571 Receives Green Light for Clinical Trials in Solid Tumors
去年
Kelun-Biotech's SKB535 Receives Approval for Clinical Trials in Advanced Solid Tumors
2年前
Myongji Hospital Develops AI-Powered Tool to Predict Ovarian Cancer Drug Resistance
去年
New Jersey Transforms Cancer Care Landscape with First Freestanding Cancer Hospital
第 1 页，共 1952 页
上一页
下一页
